| Vesicular glycolysis provides on-board energy for fast axonal transport D Zala, MV Hinckelmann, H Yu, MML Da Cunha, G Liot, FP Cordelières, ... Cell 152 (3), 479-491, 2013 | 492 | 2013 |
| Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons E Colin, D Zala, G Liot, H Rangone, M Borrell‐Pagès, XJ Li, F Saudou, ... The EMBO journal 27 (15), 2124-2134, 2008 | 423 | 2008 |
| Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis JD Godin, K Colombo, M Molina-Calavita, G Keryer, D Zala, BC Charrin, ... Neuron 67 (3), 392-406, 2010 | 349 | 2010 |
| Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies M Borrell-Pages, D Zala, S Humbert, F Saudou Cellular and Molecular Life Sciences CMLS 63 (22), 2642-2660, 2006 | 294 | 2006 |
| Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin A Benchoua, Y Trioulier, D Zala, MC Gaillard, N Lefort, N Dufour, ... Molecular biology of the cell 17 (4), 1652-1663, 2006 | 292 | 2006 |
| Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression … LP De Almeida, CA Ross, D Zala, P Aebischer, N Déglon Journal of Neuroscience 22 (9), 3473-3483, 2002 | 256 | 2002 |
| Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites G Liot, D Zala, P Pla, G Mottet, M Piel, F Saudou Journal of Neuroscience 33 (15), 6298-6309, 2013 | 196 | 2013 |
| Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons D Zala, E Colin, H Rangone, G Liot, S Humbert, F Saudou Human molecular genetics 17 (24), 3837-3846, 2008 | 194 | 2008 |
| Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease LP de Almeida, D Zala, P Aebischer, N Deglon Neurobiology of disease 8 (3), 433-446, 2001 | 192 | 2001 |
| Inhibition aspects of the bioconversion of L-phenylalanine to 2-phenylethanol by Saccharomyces cerevisiae D Stark, D Zala Enzyme and Microbial Technology 32 (2), 212-223, 2003 | 155 | 2003 |
| Releasing the brake: restoring fast axonal transport in neurodegenerative disorders MV Hinckelmann, D Zala, F Saudou Trends in cell biology 23 (12), 634-643, 2013 | 99 | 2013 |
| Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on … H Runne, E Régulier, A Kuhn, D Zala, O Gokce, V Perrin, B Sick, ... Journal of Neuroscience 28 (39), 9723-9731, 2008 | 99 | 2008 |
| Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport MV Hinckelmann, A Virlogeux, C Niehage, C Poujol, D Choquet, ... Nature communications 7 (1), 1-13, 2016 | 96 | 2016 |
| Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment D Zala, A Benchoua, E Brouillet, V Perrin, MC Gaillard, AD Zurn, ... Neurobiology of disease 20 (3), 785-798, 2005 | 92 | 2005 |
| Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington’s disease models H Zhang, C Zhang, J Vincent, D Zala, C Benstaali, M Sainlos, ... Nature communications 9 (1), 1-16, 2018 | 84 | 2018 |
| Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease JR Pineda, R Pardo, D Zala, H Yu, S Humbert, F Saudou Molecular brain 2 (1), 1-11, 2009 | 80 | 2009 |
| Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice D Zala, JC Bensadoun, LP de Almeida, BR Leavitt, CA Gutekunst, ... Experimental neurology 185 (1), 26-35, 2004 | 80 | 2004 |
| Huntingtin’s function in axonal transport is conserved in Drosophila melanogaster D Zala, MV Hinckelmann, F Saudou PloS one 8 (3), e60162, 2013 | 72 | 2013 |
| Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway JC Roux, D Zala, N Panayotis, A Borges-Correia, F Saudou, L Villard Neurobiology of disease 45 (2), 786-795, 2012 | 71 | 2012 |
| Sulfobetaine–Vinylimidazole Block Copolymers: A Robust Quantum Dot Surface Chemistry Expanding Bioimaging’s Horizons M Tasso, E Giovanelli, D Zala, S Bouccara, A Fragola, M Hanafi, Z Lenkei, ... ACS nano 9 (11), 11479-11489, 2015 | 69 | 2015 |
